UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Evolving concurrent integration of oncology and palliative care at an ESMO designated center over a decade

Annals of oncology, 2018-10, Vol.29, p.viii551-viii551

2018

Volltextzugriff (PDF)

Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment

ESMO open, 2022-10, Vol.7 (5), p.100587-100587, Article 100587

2022

Volltextzugriff (PDF)

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

Blood cancer journal (New York), 2019-08, Vol.9 (9), p.70-8, Article 70

2019

Volltextzugriff (PDF)

The first-in-class alkylating HDAC inhibitor EDO-S101 is highly synergistic with proteasome inhibition against multiple myeloma through activation of multiple pathways

Blood cancer journal (New York), 2017-07, Vol.7 (7), p.e589-e589

2017

Volltextzugriff (PDF)

P1053: ALBUMIN AND C‐REACTIVE PROTEIN PROVIDE PROGNOSTIC INFORMATION INDEPENDENTLY FROM MIPSS70 IN OVERT MYELOFIBROSIS. A RETROSPECTIVE STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.943-944

2022

Volltextzugriff (PDF)

Lymphocytosis, Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio as Prognostic Markers in CMML

Leukemia research, 2017-04, Vol.55, p.S152-S152

2017

Volltextzugriff (PDF)

PB2060: THE MDS‐SPECIFIC COMORBIDITY INDEX (MDS‐CI) PREDICTS SURVIVAL INDEPENDENTLY FROM DIPSS AND MIPSS70 IN PATIENTS WITH OVERT MYELOFIBROSIS NOT ELIGIBLE FOR ALLOGENEIC STEM CELL TRANSPLANTATION

HemaSphere, 2022-06, Vol.6 (Suppl), p.1931-1932

2022

Volltextzugriff (PDF)

The Swiss MDS Registry/Biobank: Interim-Report of Pilot Phase from a Cooperative Research Platform for Personalized Medicine in Hemato-Oncology in Switzerland

Leukemia research, 2017-04, Vol.55, p.S82-S82

2017

Volltextzugriff (PDF)

1521PEvolving concurrent integration of oncology and palliative care at an ESMO designated center over a decade

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

263 - Lymphocytosis, Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio as Prognostic Markers in CMML

Leukemia research, 2017-04, Vol.55, p.S152-S152

2017

Volltextzugriff (PDF)

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment

Leukemia research, 2021-09, Vol.108, p.106679, Article 106679.4

2021

Volltextzugriff (PDF)

The fibroblast: Sentinel cell and local immune modulator in tumor tissue

International journal of cancer, 2004-01, Vol.108 (2), p.173-180

2004

Volltextzugriff (PDF)

PS1340 ABSOLUTE MONOCYTE COUNT AFFECTS PROGNOSIS IN MYELODYSPLASTIC SYNDROMES INDEPENDENTLY FROM THE IPSS‐R

HemaSphere, 2019-06, Vol.3 (S1), p.612-n/a

2019

Volltextzugriff (PDF)

133 - The Swiss MDS Registry/Biobank: Interim-Report of Pilot Phase from a Cooperative Research Platform for Personalized Medicine in Hemato-Oncology in Switzerland

Leukemia research, 2017-04, Vol.55, p.S82-S82

2017

Volltextzugriff (PDF)

LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY

LEUKEMIA RESEARCH, 2021, Vol.108, p.S7

2021

Volltextzugriff (PDF)

A spiky issue

Blood, 2023-03, Vol.141 (13), p.1646-1646

2023

Volltextzugriff (PDF)

How Myelodysplastic Syndrome is Diagnosed

Therapeutische Umschau, 2022-03, Vol.79 (2), p.77

Silzle, Tobias

2022

Volltextzugriff (PDF)

Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations

BMC medicine, 2023-07, Vol.21 (1), p.265-265, Article 265

2023

Volltextzugriff (PDF)

Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care - Protocol for a health economic evaluation alongside a randomized controlled trial

BMC geriatrics, 2024-03, Vol.24 (1), p.231-231, Article 231

2024

Volltextzugriff (PDF)

Evaluation of Spatial/3D Audio: Basic Audio Quality Versus Quality of Experience

IEEE journal of selected topics in signal processing, 2017-02, Vol.11 (1), p.75-88

2017

Volltextzugriff (PDF)

Can knowledgeable experts assess costs and outcomes as if they were ignorant? An experiment within precision medicine evaluation

International journal of technology assessment in health care, 2023-11, Vol.40 (1), p.e4-e4, Article e4

2023

Volltextzugriff (PDF)

A hairy issue

Blood, 2014-02, Vol.123 (7), p.958-958

2014

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia Research
(6)
Blood
(4)
Blood Cancer Journal
(3)
Cancers
(3)
Cytometry. Part B, Clinical Cytometry
(3)
Hemasphere
(3)
Annals Of Oncology
(2)
American Journal Of Hematology
(1)
Annals Of Hematology
(1)
Bju International
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evolving concurrent integration of oncology and palliative care at an ESMO designated center over a decade

Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

The first-in-class alkylating HDAC inhibitor EDO-S101 is highly synergistic with proteasome inhibition against multiple myeloma through activation of multiple pathways

P1053: ALBUMIN AND C‐REACTIVE PROTEIN PROVIDE PROGNOSTIC INFORMATION INDEPENDENTLY FROM MIPSS70 IN OVERT MYELOFIBROSIS. A RETROSPECTIVE STUDY

Lymphocytosis, Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio as Prognostic Markers in CMML

PB2060: THE MDS‐SPECIFIC COMORBIDITY INDEX (MDS‐CI) PREDICTS SURVIVAL INDEPENDENTLY FROM DIPSS AND MIPSS70 IN PATIENTS WITH OVERT MYELOFIBROSIS NOT ELIGIBLE FOR ALLOGENEIC STEM CELL TRANSPLANTATION

The Swiss MDS Registry/Biobank: Interim-Report of Pilot Phase from a Cooperative Research Platform for Personalized Medicine in Hemato-Oncology in Switzerland

1521PEvolving concurrent integration of oncology and palliative care at an ESMO designated center over a decade

263 - Lymphocytosis, Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio as Prognostic Markers in CMML

I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment

O08 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY

The fibroblast: Sentinel cell and local immune modulator in tumor tissue

PS1340 ABSOLUTE MONOCYTE COUNT AFFECTS PROGNOSIS IN MYELODYSPLASTIC SYNDROMES INDEPENDENTLY FROM THE IPSS‐R

Guideline-based indicators for adult patients with myelodysplastic syndromes

133 - The Swiss MDS Registry/Biobank: Interim-Report of Pilot Phase from a Cooperative Research Platform for Personalized Medicine in Hemato-Oncology in Switzerland

LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY

A spiky issue

How Myelodysplastic Syndrome is Diagnosed

Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations

Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care - Protocol for a health economic evaluation alongside a randomized controlled trial

Evaluation of Spatial/3D Audio: Basic Audio Quality Versus Quality of Experience

Can knowledgeable experts assess costs and outcomes as if they were ignorant? An experiment within precision medicine evaluation

A hairy issue

Suchergebnisse filtern